汇宇制药：公司持有同源康股份情况可关注公司定期报告

Core Viewpoint - The company will decide on potential share reductions based on development needs and the stock price fluctuations of Tongyuan Kang [1] Summary by Relevant Sections - Company Holdings: The company holds shares in Tongyuan Kang and will provide updates on its holdings in regular reports [1]